BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32598349)

  • 1. Antihypertensive drug use and prostate cancer-specific mortality in Finnish men.
    Siltari A; Murtola TJ; Talala K; Taari K; Tammela TLJ; Auvinen A
    PLoS One; 2020; 15(6):e0234269. PubMed ID: 32598349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive drugs and prostate cancer survival after radical prostatectomy in Finland-A nationwide cohort study.
    Santala EE; Rannikko A; Murtola TJ
    Int J Cancer; 2019 Feb; 144(3):440-447. PubMed ID: 30110124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort.
    Joentausta RM; Rannikko A; Murtola TJ
    Prostate; 2019 May; 79(6):583-591. PubMed ID: 30652328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive drugs and prostate cancer risk in a Finnish population-based cohort.
    Siltari A; Murtola TJ; Talala K; Taari K; Tammela TLJ; Auvinen A
    Scand J Urol; 2018; 52(5-6):321-327. PubMed ID: 30698056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer prognosis after initiation of androgen deprivation therapy among statin users. A population-based cohort study.
    Peltomaa AI; Raittinen P; Talala K; Taari K; Tammela TLJ; Auvinen A; Murtola TJ
    Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):917-924. PubMed ID: 33790420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer.
    Kinnunen PTT; Murtola TJ; Talala K; Taari K; Tammela TLJ; Auvinen A
    BMC Cancer; 2017 Aug; 17(1):585. PubMed ID: 28851310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy.
    Grytli HH; Fagerland MW; Fosså SD; Taskén KA; Håheim LL
    Prostate; 2013 Feb; 73(3):250-60. PubMed ID: 22821802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate Cancer-specific Survival After Radical Prostatectomy Is Improved Among Metformin Users but Not Among Other Antidiabetic Drug Users.
    Joentausta RM; Rannikko A; Murtola TJ
    Eur Urol Open Sci; 2021 Dec; 34():86-93. PubMed ID: 34934970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
    Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
    Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follow-up.
    Studer UE; Whelan P; Wimpissinger F; Casselman J; de Reijke TM; Knönagel H; Loidl W; Isorna S; Sundaram SK; Collette L;
    Eur Urol; 2014 Nov; 66(5):829-38. PubMed ID: 23932338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of urothelial cancer death among people using antihypertensive drugs-a cohort study from Finland.
    Santala EEE; Kotsar A; Veitonmäki T; Tammela TLJ; Murtola TJ
    Scand J Urol; 2019 Aug; 53(4):185-192. PubMed ID: 31250699
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08.
    Voog JC; Paulus R; Shipley WU; Smith MR; McGowan DG; Jones CU; Bahary JP; Zeitzer KL; Souhami L; Leibenhaut MH; Rotman M; Husain SM; Gore E; Raben A; Chafe S; Sandler HM; Efstathiou JA
    Eur Urol; 2016 Feb; 69(2):204-10. PubMed ID: 26362090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between statin use and progression in men with prostate cancer treated with primary androgen deprivation therapy.
    Mikkelsen MK; Thomsen FB; Berg KD; Jarden M; Larsen SB; Hansen RB; Brasso K
    Scand J Urol; 2017 Dec; 51(6):464-469. PubMed ID: 28831860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
    Grytli HH; Fagerland MW; Fosså SD; Taskén KA
    Eur Urol; 2014 Mar; 65(3):635-41. PubMed ID: 23351721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial.
    Veitonmäki T; Murtola TJ; Määttänen L; Taari K; Stenman UH; Tammela TL; Auvinen A
    Prostate; 2015 Sep; 75(13):1394-402. PubMed ID: 26073992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of socioeconomic status on stage specific prostate cancer survival and mortality before and after introduction of PSA test in Finland.
    Seikkula HA; Kaipia AJ; Ryynänen H; Seppä K; Pitkäniemi JM; Malila NK; Boström PJ
    Int J Cancer; 2018 Mar; 142(5):891-898. PubMed ID: 29044563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.
    Murtola TJ; Peltomaa AI; Talala K; Määttänen L; Taari K; Tammela TLJ; Auvinen A
    Eur Urol Focus; 2017 Apr; 3(2-3):212-220. PubMed ID: 28753762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation.
    Aizawa R; Takayama K; Nakamura K; Inoue T; Yamasaki T; Kobayashi T; Akamatsu S; Ogawa O; Mizowaki T
    Int J Clin Oncol; 2019 Oct; 24(10):1247-1255. PubMed ID: 31152322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of prostate cancer mortality and cardiovascular mortality of nonmetastatic prostate cancer patients: A population-based retrospective cohort study.
    Matthes KL; Pestoni G; Korol D; Van Hemelrijck M; Rohrmann S
    Urol Oncol; 2018 Jun; 36(6):309.e15-309.e23. PubMed ID: 29576269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive medications and survival in patients with cancer: a population-based retrospective cohort study.
    Holmes S; Griffith EJ; Musto G; Minuk GY
    Cancer Epidemiol; 2013 Dec; 37(6):881-5. PubMed ID: 24075077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.